Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.31 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5411373 | 0.82 | — | — | |
| SCHEMBL5405590 | 0.80 | GAA (0.50) | ALDH1A1MGAMGAASIMGAM2 | |
| SCHEMBL28195469 | 0.77 | — | — | |
| SCHEMBL11752232 | 0.77 | LMNA (0.44) | ALDH1A1GRIK1GRIK2 | |
| SCHEMBL21848016 | 0.76 | FFAR3 (0.33) | ALDH1A1FFAR3 | |
| SCHEMBL775029 | 0.76 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL12670437 | 0.73 | TSHR (0.36) | MGAMGAASIMGAM2KDM4E | |
| SCHEMBL3110359 | 0.72 | — | — | |
| SCHEMBL13742820 | 0.72 | — | — | |
| SCHEMBL3110355 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7157599-B2 | Method of producing α,β-unsaturated carboxylic acid compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-01-02 | — | — | US | disclosed |
| US-20050277786-A1 | Method of producing alpha, beta-unsaturated carboxylic acid compounds | SUMITOMO CHEMICAL COMPANY, LIMITED | 2005-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050277786-A1 | Method of producing alpha, beta-unsaturated carboxylic acid compounds | ACSL1, ACSL6, ACSL3 | ALDH1A1 45/4885TDP1 4706/4885FFAR3 354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.